The FDA approved Vabomere (meropenem + vaborbactam)( formerly Carbavance),from Rempex Pharmaceuticals, for adults with complicated urinary tract infections (cUTI), including...
Melinta Therapeutics, Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA)...
The Medicines Company announced that it has entered into a definitive agreement to sell its infectious disease business unit to...